Cotto, Kelsy C. http://orcid.org/0000-0003-0890-6889
Feng, Yang-Yang http://orcid.org/0000-0002-6347-6749
Ramu, Avinash
Richters, Megan http://orcid.org/0000-0002-5491-2537
Freshour, Sharon L.
Skidmore, Zachary L.
Xia, Huiming http://orcid.org/0000-0003-2571-1880
McMichael, Joshua F. http://orcid.org/0000-0002-0197-2245
Kunisaki, Jason
Campbell, Katie M. http://orcid.org/0000-0001-6491-4432
Chen, Timothy Hung-Po
Rozycki, Emily B.
Adkins, Douglas
Devarakonda, Siddhartha
Sankararaman, Sumithra
Lin, Yiing http://orcid.org/0000-0002-0317-7608
Chapman, William C.
Maher, Christopher A. http://orcid.org/0000-0002-9035-603X
Arora, Vivek http://orcid.org/0000-0003-1694-9109
Dunn, Gavin P.
Uppaluri, Ravindra http://orcid.org/0000-0001-5988-6828
Govindan, Ramaswamy http://orcid.org/0000-0002-6964-9612
Griffith, Obi L. http://orcid.org/0000-0002-0843-4271
Griffith, Malachi http://orcid.org/0000-0002-6388-446X
Funding for this research was provided by:
V Foundation for Cancer Research (V2018-007)
Article History
Received: 30 December 2020
Accepted: 8 March 2023
First Online: 22 March 2023
Competing interests
: W.C.C serves on the advisory board for Novartis Pharmaceutical and reports intellectual property with Pathfinder Therapeutics. R.U. reports grants and personal fees from Merck Inc. R.G. served as consultant for Horizon Pharmaceuticals and GenePlus. The remaining authors declare no competing interests.
: Animal studies and human subjects research involved in this project were reviewed by the Washington University School of Medicine Institutional Animal Care and Use Committee, Human Research Protections Office and Institutional Review Board (IRB #201810230 and #202001196).